Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell receptor alpha variable 9-1 (TRAV9-1) is a protein-coding gene segment that encodes the variable region (V region) of the alpha chain of the **T cell receptor (TCR)** complex[1][2]. This segment participates in **antigen recognition** as part of the highly variable alpha chain expressed by T lymphocytes. The alpha-beta TCR is essential for adaptive immunity; it recognizes peptides presented by major histocompatibility complex (MHC) molecules on antigen presenting cells, triggering T cell activation and downstream signaling pathways involved in immune responses[1][3]. TRAV9-1 is one of many V segments that, through somatic recombination during T cell development, generate the diversity of antigen recognition seen in T cell repertoires[1][3]. Variability at this segment contributes to the specificity of individual T cells, but by itself does not define a therapeutic target, as it is *one of many possible variable region gene segments*; typically, therapeutic targeting involves entire TCRs (such as TCR-engineered T cell therapies) or the complex as a whole, rather than any specific V gene segment[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor alpha variable 9-1 (TRAV9-1).